This article is more than 5 years old. Information may no longer be current.

ArthroCare announces CE Mark for wound debridement device

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced on its website that its WoundWand Debridement Device (WoundWand) is CE (Conformité Européenne) marked and is available for distribution in Europe.

The WoundWand uses ArthroCare's patented Coblation technology to enable necrotic tissue to be removed from a wound in a precise and controlled manner, the company noted. It is intended for wound debridement in acute and chronic wounds and wound cleansing by removal of necrotic tissue.

The WoundWand is not available for sale in the United States.